Oncology Events Calendar
Discover conferences, symposia and other events worldwide.
View monthly calendar
Submit your event
233 event(s) found
TROG 2026
TROG 2026 organized by TROG Cancer Research
17/03/2026 - 20/03/2026
In-person
TROG Cancer Research
Melbourne, VIC, Australia
TBD
2nd International Cancer & Immuno-Oncology Conference
The 2nd Edition of International Cancer & Immuno-Oncology Conference (CIOC 2026) is set to take place from March 19-21, 2026, in Singapore and virtually. Designed to foster innovation and collaboration in oncology, this hybrid event will bring together leading experts to discuss advancements in cancer research under the theme "Transforming Cancer Care: Innovations, Integrations, and Impact". With a focus on translating research breakthroughs into clinical practice, the conference will serve as a global platform to explore cutting-edge developments in cancer biology, prevention, and treatment strategies.
18/03/2026 - 20/03/2026 Hybrid Magnus Group Singapore, Singapore Village Hotel Changi
TOGA Masterclass Small Cell Lung Cancer
TOGA Masterclass Small Cell Lung Cancer organized by TOGA
20/03/2026 - 20/03/2026 In-person TOGA Melbourne, VIC, Australia TBD
4th PACRI International Meeting
The 4th PACRI International Annual Meeting is set to bring together African and global experts in cancer research, clinical practice, policy, and advocacy to explore how we can drive transformative change in cancer care across Africa. This conference will provide a dynamic platform for multi-disciplinary discussions on bridging the gap between cutting-edge cancer science and its real-world applications. Ensuring that innovation, equity, and patient-centered care shape the future of cancer treatment and prevention in Africa will be at the core of this event. With an emphasis on advancing cancer research and care, the conference will cover the latest breakthroughs in precision oncology, genomics, artificial intelligence (AI), and the critical role of the exposome in cancer risk, particularly in African populations. Through detailed discussions, delegates will examine how these innovations can be integrated into healthcare systems across Africa, providing an opportunity for researchers and clinicians to address the urgent need for more personalized treatments and early detection methods that consider the unique genetic, environmental, and socio-economic factors that contribute to cancer in the region. A key focus will also be placed on the intersection between cancer and infectious diseases, recognizing the significant burden of co-morbid infections, such as HIV, HPV, and hepatitis, in Africa and their role in cancer development and progression. This will include discussions on how integrated approaches can enhance cancer prevention and treatment strategies. Additionally, the role of cultural practices in shaping cancer care and patient outcomes will be examined, ensuring that research and clinical interventions are aligned with the cultural contexts and traditions of African communities.
21/03/2026 - 24/03/2026 Hybrid University of Pretoria PACRI, NCCRC, AAIMHS Johannesburg, South Africa The MaslowEBMT 52nd Annual Meeting
The EBMT 2026 in Madrid offers a unique opportunity to connect with experts and engage in the latest scientific developments. It is a key event for professionals in transplantation and cellular therapy, featuring specialised sessions for Physicians, Nurses, Data Managers, Statisticians, Quality Managers, Cell Therapists, Paediatricians, Pharmacists, Psychologists, Transplant Coordinators, Lab Scientists, Trainees, as well as Patients, Family Members and Donors.
21/03/2026 - 24/03/2026 In-person EBMT Madrid, Spain IFEMA Madrid BIO-Europe Spring®
BIO-Europe Spring brings together the global life science community, facilitating more than 20,000 one-to-one partnering meetings.
22/03/2026 - 24/03/2026 In-person Informa Lisbon, Portugal Feira Internacional de Lisboa EHA ReCon 2026
EHA is proud to announce the fou‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.rth edition of the EHA Research Conference, titled ‘From cradle to grave: normal and malignant hematopoiesis in young and aged settings.’ ‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.‘EHA ReCon’ is a great opportunity for researchers from all over the world who are deeply invested in the field of hematology. It aims to advance both basic and translational research. Attendees will benefit from an intimate but focused setting that fosters in-depth discussions, networking, and collaboration. Spanning 3.5 days, this format sets the conference apart from the broader, more clinically-oriented EHA Congress.
22/03/2026 - 25/03/2026 In-person European Hematology Association (EHA) Espoo, Finland DIPOLI – Aalto University 11th International School of Immunotherapy: Targeting Immune Aging
Welcome to the 11th edition of our International Immunotherapy School. This year, we have invited leading experts from around the world to examine how aging reshapes immune cell development, tissue immunity, and systemic inflammation—and how these processes drive cancer, cardiovascular disease, neurodegeneration, and impaired host defense. The course integrates foundational immunology with emerging human and translational data, with a focus on actionable pathways and therapeutic strategies to restore immune balance in older adults. It is designed for graduate students, postdoctoral fellows, clinicians, and investigators interested in aging biology, immunology, and translational medicine. The 3-day course will be online via Zoom and feature live interactions with Postdocs, Ph.D. students and junior faculty from four continents.
23/03/2026 - 25/03/2026 Virtual Icahn School of Medicine at Mount Sinai, Sorbonne Université, Institut Curie, Universidade de São Paulo, Nantes Université, International Union of Immunology Societies Brazil Zoom AACR Special Conference in Cancer Research: Brain Cancer
Held every 3 years, the AACR Special Conference on Brain Cancer brings together a multidisciplinary community of researchers and clinicians to address one of the most lethal and biologically complex forms of cancer. The 2026 meeting, taking place March 23–25 in Philadelphia, will continue this tradition by highlighting advances in both adult and pediatric brain tumors, from glioblastoma and medulloblastoma to rarer CNS subtypes. The program will spotlight the neuroscience of gliomas, advances in neuro-immuno-oncology, cellular therapies for nervous system tumors, brain borders and CNS trafficking, next-generation diagnostics and biomarkers, updates in brain metastases and leptomeningeal disease, strategies to solve tumor heterogeneity using spatial and 3D genomics, and the latest in clinical trials.
23/03/2026 - 25/03/2026 In-person AACR Philadelphia, PA, United States Philadelphia Marriott Downtown
2026 SITC Spring Scientific: Next-generation Cellular Therapies, T cell Engagers, and Combinations
The 2026 SITC Spring Scientific will bring together experts in cell therapy, drug development, and immuno-oncology to address the timely topic of next-generation cellular therapies, T cell engagers, and combination therapies to treat cancer. The program will feature in-depth explorations and discussions of recent scientific breakthroughs, cutting-edge technologies, and the newest clinical studies that address the development and advancement of novel immuno-oncology agents and how these agents can be combined with other therapies to overcome tumor evasion of immunity.
24/03/2026 - 26/03/2026 Hybrid SITC Tuscon, AZ, United States El Conquistador Tucson
CISCON I: 1er Congrès international de la Société camerounaise d’oncologie
In French: "Sous le haut patronage du Ministère de la Santé Publique du Cameroun, la Société camerounaise d’oncologie (SCON) organise son tout premier Congrès international du 25 au 27 mars 2026 à Siga Bonjo (Littoral, Cameroun). Le thème central : « Défis de la prise en charge des cancers et couverture santé universelle en Afrique »."
24/03/2026 - 26/03/2026 In-person SCON Siga Bonjo, Cameroon TBD
15th European Breast Cancer Conference
In 1998, the European Breast Cancer Conference was set up to provide a platform for breast cancer specialists and patients to discuss the multidisciplinary approach to breast cancer care. It provided the specialists with the latest updates in treatment. It was the first conference of its kind, which had a patient advocacy organisation as a partner, ensuring that latest information reached the patients. A truly multidisciplinary collaboration and education is needed in breast cancer with an approach to provide equality across borders.
24/03/2026 - 26/03/2026 In-person EBC Council Barcelona, Spain CCIB
Congrès de la SFH 2026
Coming soon (in French)...
24/03/2026 - 26/03/2026 In-person Société Française d'Hématologie (SFH) Paris, France Palais des Congrès (Porte Maillot) Autophagy in cell death, inflammation and cancer: issues we need to digest
BACR webinar on autophagy. Guest Speaker: Kevin Ryan (Senior Group Leader, CRUK Scotland Institute, University of Glasgow). Open to anyone who wishes to join.
25/03/2026 - 25/03/2026 Virtual BACR Glasgow, United Kingdom Online ELCC 2026
ELCC 2026 organized by IASLC
25/03/2026 - 29/03/2026 Hybrid IASLC Copenhagen, Denmark TBD ANZGOG 2026
ANZGOG 2026 organized by ANZGOG
25/03/2026 - 27/03/2026 In-person ANZGOG Gold Coast, QLD, Australia TBD 8th Translational Research Conference: Multiple Myeloma
An outstanding faculty of myeloma experts will present the most recent advances and perspectives in the field of plasma disorders from pathophysiology to diagnosis and therapy. The plenary conference program is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants will further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in the field, including during small Meet the Expert sessions and Mentored Posters Walks. Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
25/03/2026 - 27/03/2026 In-person European School of Haematology (ESH) Stockholm, Sweden Clarion Hotel Stockholm Symposium Lilly au congrès de la SFH
In French: "À l'ère des nouvelles stratégies thérapeutiques dans la LLC et le LCM : Comment emmener les patients plus loin ?"
26/03/2026 - 26/03/2026 In-person Paris, France Palais des Congrès de Paris
7th Immune Effector Cell Therapies in Multiple Myeloma Workshop
Coming soon...
26/03/2026 - 27/03/2026 In-person International Myeloma Society (IMS) Boston, MA, United States Boston Marriott Long Wharf XII Jornadas Valencianas de LMA 2026
Symposium dedicated to the treatment of patients with acute myeloid leukemia, featuring experts from around Spain and held in Spanish.
26/03/2026 - 26/03/2026 Hybrid PETHEMA Sagunto (Valencia), Spain To be announced…
HACKATHON A.R.CA.D 2026
In French: "Du 27 au 29 mars 2026, la Fondation A.R.CA.D organise le plus grand week-end d’innovation européen consacré à l’oncologie digestive. Les cancers digestifs représentent 100 000 nouveaux cas par an, soit près de 25% des cancers en France. L’innovation peut changer la donne : c’est simple et accessible à tous ! Imaginez qu’avec votre smartphone, une application mobile vous rappelle automatiquement vos examens, qu’un modèle 3D imprimable du côlon ou de la lésion permette aux chirurgiens de se préparer avant l’opération, qu’un protocole d’essai clinique soit travaillé avec l’ensemble des parties prenantes. Toutes ces idées, peuvent devenir réalité lors de ce week-end d’innovation. Comment ça marche ? 1. Déposez votre concept, même s’il tient sur un bout de papier. 2. Si vous faites partis des 15 projets sélectionné, constituez ou rejoignez une équipe mixte (patients, soignants, étudiants…) avec les personnes présentes au hackathon. 3. En 48 h, transformez votre idée en prototype fonctionnel et bénéficiez du soutien d’expert(e)s et d’ateliers de coaching. À qui s’adresse cet hackathon ? Tout le monde : patient(e), patient(e) expert(e), étudiant(e), professionnel(le) de santé, membre d’une association ou simplement une personne curieuse ou intéressée, si vous avez une idée, même embryonnaire, pour améliorer le dépistage, la recherche, la prise en charge ou le parcours de soins, vous êtes au bon endroit. Si vous êtes seuls, n’hésitez pas non plus, des équipes n’attendent plus que vous ! Pourquoi participer ? Des prix d’accompagnement (mentorat, mise en relation, incubation) et une visibilité nationale vous permettront de lancer plus rapidement votre solution, pour un impact concret au service des patient(e)s."
27/03/2026 - 29/03/2026 In-person Fondation ARCAD Paris, France More info coming soon…
Florida Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
27/03/2026 - 27/03/2026 In-person Blood Cancer United Fort Lauderdale, FL, United States Marriott Harbor
Journée Inter-Cancéropôles Nord-Ouest et Grand Ouest : “La place des Sciences Humaines et Sociales en oncologie »
In French: "Les Cancéropôles sont des acteurs majeurs de la structuration de la recherche interrégionale en cancérologie. Leur objectif est de faire interagir les forces pluridisciplinaires de leurs territoires respectifs afin d’apporter des expertises complémentaires pour faire avancer la recherche sur le cancer. Champ lui-même pluridisciplinaire, celui des Sciences Humaines et Sociales (SHS) joue un rôle incontournable dans cette recherche."
09/04/2026 - 09/04/2026 In-person Cancéropôle Grand Ouest, Cancéropôle Nord-Ouest Rennes, France Ecole des hautes études en santé publique (EHESP)
iwMyeloma 2026
We are thrilled to announce that iwMyeloma 2026, the 19th workshop exploring myeloma, will take place in person from 10-12 April next year in Miami, Florida. This event will bring together the world’s leading clinical researchers to share their insights on integrating evolving myeloma understanding into clinical practice to optimize patient care.
09/04/2026 - 11/04/2026 In-person World Health Communications Miami, FL, United States TBD